¼¼°èÀÇ ÇコÄɾî¿ë ³ª³ë ·Îº¿ ½ÃÀå
Nanorobots in Healthcare
»óǰÄÚµå : 1644232
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 152 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÇコÄɾî¿ë ³ª³ë ·Îº¿ ½ÃÀåÀº 2030³â±îÁö 110¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 78¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ÇコÄɾî¿ë ³ª³ë ·Îº¿ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 5.9%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 110¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ³ª³ë¸Å´Ïǽ·¹ÀÌÅÍ´Â CAGR 5.7%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 84¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹ÙÀÌ¿À¡¤³ª³ë ·Îº¸Æ½½º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 8.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 20¾ï ´Þ·¯, Áß±¹Àº CAGR 5.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÇコÄɾî¿ë ³ª³ë ·Îº¿ ½ÃÀåÀº 2024³â¿¡ 20¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 18¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 5.6%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 5.2%¿Í 5.1%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÇコÄɾî¿ë ³ª³ë ·Îº¿ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÇコÄɾî¿ë ³ª³ë·Îº¿À̶õ ¹«¾ùÀ̸ç, ÇコÄɾ¼­ ³ª³ë·Îº¿Àº ¾î¶»°Ô ÀÇÇп¡ Çõ¸íÀ» ÀÏÀ¸Å°°í Àִ°¡?

ÇコÄɾî¿ë ³ª³ë·Îº¿Àº ¼¼Æ÷ ¹× ºÐÀÚ ¼öÁØ¿¡¼­ ¸Å¿ì Á¤¹ÐÇÑ ÀÇ·á ÀÛ¾÷À» ¼öÇàÇϵµ·Ï ¼³°èµÈ ³ª³ë ½ºÄÉÀÏÀÇ ·Îº¿ Àåºñ¸¦ ¸»ÇÕ´Ï´Ù. ÀÌ ¹Ì¼¼ÇÑ ±â°è´Â ÀÎü¸¦ Ž»öÇϰí, ¾à¹°À» Àü´ÞÇϰí, Áø´ÜÀ» ³»¸®°í, ½ÉÁö¾î ¿Ü°ú¼ö¼úÀ» ¼öÇàÇϱâ À§ÇØ ¼³°èµÇ¾ú½À´Ï´Ù. ±âÁ¸ÀÇ ÀÇ·á Åø¿Í ´Þ¸® ³ª³ë·Îº¿Àº Ç÷·ù, Á¶Á÷ µî ¾î·Æ°í Á¦ÇÑµÈ »ý¹°ÇÐÀû ȯ°æ ³»¿¡¼­ ÀÛµ¿ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» Á¦°øÇÏ¿© ¾Ï, ½ÉÇ÷°ü Áúȯ, ½Å°æ ÅðÇ༺ Áúȯ°ú °°Àº Áúº´À» Ä¡·áÇÒ ¼ö Àִ ȹ±âÀûÀÎ Á¢±Ù¹ýÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ³ª³ë·Îº¿ÀÇ °¡´É¼ºÀº Ä¡·á»Ó¸¸ ¾Æ´Ï¶ó ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× ¿¹¹æÀû °Ç°­°ü¸® ±â´ÉÀ» Á¦°øÇÏ¿© ¹Ì·¡ ÀÇ·á ¹ßÀüÀÇ Ãʼ®ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀº ³ª³ë ·Îº¿ÀÇ ´É·ÂÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

±â¼ú Çõ½ÅÀº ³ª³ë ·Îº¿ÀÇ ´É·ÂÀ» Å©°Ô Çâ»ó½ÃÄÑ ÀÌ·ÐÀû °³³ä¿¡¼­ ½Ç¿ëÀûÀÎ ÇコÄɾî Åø·Î Å»¹Ù²Þ½ÃÄ×½À´Ï´Ù. ¿øÀÚÃþ ÁõÂø¹ý, DNA Á¾ÀÌÁ¢±â µî ³ª³ë °¡°ø ±â¼úÀÇ ¹ßÀüÀ¸·Î ³ª³ë ·Îº¿ÀÇ Á¤¹ÐÇÑ ¼³°è¿Í Á¶¸³ÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×(ML)ÀÇ ÅëÇÕÀº º¹ÀâÇÑ »ýü ½Ã½ºÅÛÀ» ÀÚÀ²ÀûÀ¸·Î Ž»öÇϰí ȯ°æ Àڱؿ¡ µû¶ó ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ´Â ´É·ÂÀ» °­È­ÇÕ´Ï´Ù. ÀÚ±â ¹× ÃÊÀ½ÆÄ ÃßÁø ¸ÞÄ¿´ÏÁòÀ» ÅëÇØ ü³» ³ª³ë ·Îº¿ÀÇ À̵¿ Á¦¾î°¡ °³¼±µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ »ýºÐÇØ¼º ¼ÒÀçÀÇ °³¹ß·Î ÀÎÇØ ÀÌ·¯ÇÑ Àåºñ´Â ¿ªÇÒÀ» ´ÙÇÏ¸é ¾ÈÀüÇÏ°Ô ¿ëÇØµÇ¾î Àå±âÀûÀÎ ÇÕº´ÁõÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¹±âÀûÀÎ ¹ßÀüÀº ´Ù¾çÇÑ ÀÇ·á ¿ëµµ¿¡¼­ ³ª³ë ·Îº¿ÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ¿© º¸´Ù È¿À²ÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖÀ¸¸ç ´Ù¿ëµµÇÑ ³ª³ë ·Îº¿ÀÇ »ç¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ³ª³ë ·Îº¿ ¼ö¿ä¸¦ ÁÖµµÇÏ´Â ¿ëµµ´Â ¹«¾ùÀΰ¡?

³ª³ë·Îº¿Àº ±× Á¤¹Ðµµ¿Í ±â´É¼ºÀ¸·Î ÀÎÇØ ´Ù¾çÇÑ ¿ëµµ¿¡¼­ äÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¾à¹°Àü´ÞÀº Áß¿äÇÑ ºÐ¾ßÀ̸ç, ³ª³ë ·Îº¿Àº Ä¡·áÁ¦¸¦ Áúº´ ¼¼Æ÷¿¡ Á÷Á¢ ¿î¹ÝÇÏ¿© ºÎÀÛ¿ëÀ» ÁÙÀ̰í Ä¡·á È¿°ú¸¦ Çâ»ó½ÃŰ´Â µ¥ »ç¿ëµË´Ï´Ù. Á¾¾çÇп¡¼­ ÀÌ·¯ÇÑ Àåºñ´Â Ç¥ÀûÈ­µÈ ¾à¹°Àü´Þ°ú Á¾¾çÀÇ Á¶±â ¹ß°ßÀ» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ¾Ï Ä¡·á¿¡ º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. ½ÉÇ÷°ü ºÐ¾ß¿¡¼­´Â µ¿¸Æ ¸·ÈûÀ» Á¦°ÅÇÏ°í ¼Õ»óµÈ Á¶Á÷À» º¹±¸ÇÏ´Â µ¥ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. Áø´ÜÇп¡¼­´Â ³ª³ë¼¾¼­¸¦ žÀçÇÑ ³ª³ë·Îº¿ÀÌ ¹ÙÀÌ¿À¸¶Ä¿¿¡ ´ëÇÑ ½Ç½Ã°£ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© ´ç´¢º´À̳ª °¨¿°°ú °°Àº Áúº´À» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ½Å°æ ¼Õ»ó º¹±¸³ª ½ÅÀå °á¼® Á¦°Å¿Í °°Àº ÷´Ü ¼ö¼úµµ ³ª³ë·Îº¿ ±â¼úÀ» ¸ð»öÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àç»ýÀÇ·á¿Í À¯ÀüÀÚ Ä¡·á´Â ³ª³ë·Îº¿ÀÌ ¼¼Æ÷ º¹±¸¿Í À¯ÀüÀÚ º¯Çü¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ½ÅÈï ºÐ¾ßÀÔ´Ï´Ù.

ÇコÄÉ¾î ºÐ¾ß ³ª³ë ·Îº¿ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

ÇコÄÉ¾î ºÐ¾ßÀÇ ³ª³ë ·Îº¿ ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, ÀÇ·á ¼ö¿äÀÇ ÁøÈ­, ³ª³ë ±â¼ú ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¾Ï, ½ÉÇ÷°ü Áúȯ, ´ç´¢º´°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡´Â Á¤¹Ð Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁõÆø½ÃŰ°í ³ª³ë ·Îº¿ÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ³ª³ë ¼ÒÀç, ÃßÁø ½Ã½ºÅÛ ¹× AIÀÇ ±â¼ú ¹ßÀüÀº ÀÌ·¯ÇÑ ÀåºñÀÇ ´É·Â°ú ½Å·Ú¼ºÀ» Çâ»ó½ÃÄÑ º¹ÀâÇÑ ÀÇ·á ÀýÂ÷¿¡ ´ëÇÑ »ç¿ëÀ» Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ Áúº´À» Á¶±â¿¡ Á¤È®ÇÏ°Ô °¨ÁöÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ» ã°í ÀÖÀ¸¹Ç·Î Áø´Ü ¹× ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ ¿ëµµ°¡ È®´ëµÇ°í ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ³ª³ëÅ×Å©³î·¯ÁöÀÇ ¹ßÀüÀ» À§ÇÑ Á¤ºÎÀÇ ±¸»ó°ú ÀÚ±Ý Áö¿ø, ¿¬±¸±â°ü°ú ¾÷°è °ü°èÀÚµéÀÇ ÆÄÆ®³Ê½Ê È®´ë´Â ±â¼ú Çõ½ÅÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡¿Í Àúħ½ÀÀû Ä¡·á·ÎÀÇ ÀüȯÀº ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ³ª³ë·Îº¿¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖÀ¸¸ç, ÇâÈÄ 10³â°£ ¾ÈÁ¤ÀûÀÎ ¼ºÀåÀ» ±â´ëÇÒ ¼ö ÀÖ´Â ½ÃÀåÀ¸·Î ÀÚ¸®¸Å±èÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÎ¹®

À¯Çü(³ª³ë ¸Å´Ïǽ·¹ÀÌÅÍ, ¹ÙÀÌ¿À ³ª³ë ·Îº¸Æ½½º, ÀÚ±âÀ¯µµ ³ª³ë ·Îº¿), ¾ÖÇø®ÄÉÀ̼Ç(Ÿ±ê ¾à¹°Àü´Þ ¾ÖÇø®ÄÉÀ̼Ç, ¸ÞµðÄà À̹Ì¡ ¾ÖÇø®ÄÉÀ̼Ç, ¿Ü°ú ¾ÖÇø®ÄÉÀ̼Ç, Ä¡°ú ¾ÖÇø®ÄÉÀ̼Ç, ±âŸ ¾ÖÇø®ÄÉÀ̼Ç)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 48»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Nanorobots in Healthcare Market to Reach US$11.0 Billion by 2030

The global market for Nanorobots in Healthcare estimated at US$7.8 Billion in the year 2024, is expected to reach US$11.0 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Nanomanipulators, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$8.4 Billion by the end of the analysis period. Growth in the Bio-Nanorobotics segment is estimated at 8.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 5.6% CAGR

The Nanorobots in Healthcare market in the U.S. is estimated at US$2.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 5.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Nanorobots in Healthcare Market - Key Trends & Drivers Summarized

What Are Nanorobots in Healthcare, and How Are They Revolutionizing Medical Science?

Nanorobots in healthcare refer to nanoscale robotic devices designed to perform highly precise medical tasks at a cellular or molecular level. These microscopic machines are engineered to navigate the human body, delivering drugs, performing diagnostics, and even conducting surgical procedures with unparalleled accuracy. Unlike conventional medical tools, nanorobots offer the ability to operate within challenging and confined biological environments, such as bloodstreams or tissues, enabling revolutionary approaches to treating diseases like cancer, cardiovascular disorders, and neurodegenerative conditions. The potential of nanorobots extends beyond treatment, offering capabilities for real-time monitoring and preventive healthcare, making them a cornerstone of future medical advancements.

How Are Technological Breakthroughs Enhancing Nanorobot Capabilities?

Technological innovations have significantly elevated the capabilities of nanorobots, transforming them from theoretical concepts into practical healthcare tools. Advances in nanofabrication techniques, such as atomic layer deposition and DNA origami, allow for the precise design and assembly of nanorobots. Integration of artificial intelligence (AI) and machine learning (ML) enhances their ability to navigate complex biological systems autonomously and make decisions based on environmental stimuli. Magnetic and ultrasonic propulsion mechanisms now provide improved control over nanorobot movement within the body. Moreover, developments in biodegradable materials ensure that these devices safely dissolve after completing their tasks, minimizing risks of long-term complications. These breakthroughs are driving the adoption of nanorobots across various medical applications, making them more efficient, reliable, and versatile.

Which Applications Are Driving Demand for Nanorobots in Healthcare?

Nanorobots are witnessing increasing adoption across a range of applications, driven by their precision and functionality. Drug delivery is a key area, where nanorobots are used to transport therapeutic agents directly to diseased cells, reducing side effects and improving treatment efficacy. In oncology, these devices are transforming cancer treatment by enabling targeted drug delivery and early detection of tumors. Cardiovascular applications include clearing arterial blockages and repairing damaged tissues. In diagnostics, nanorobots equipped with nanosensors provide real-time data on biomarkers, enabling early detection of diseases like diabetes or infections. Advanced surgical procedures, such as repairing neural damage or clearing kidney stones, are also exploring nanorobot technology. Additionally, regenerative medicine and gene therapy are emerging areas where nanorobots are playing a crucial role in cellular repair and genetic modifications.

What Factors Are Driving the Growth of the Nanorobots in Healthcare Market?

The growth in the nanorobots in healthcare market is driven by several factors, including technological advancements, evolving medical needs, and increasing investments in nanotechnology research. Rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and diabetes has amplified the demand for precision treatment options, boosting the adoption of nanorobots. Technological progress in nanomaterials, propulsion systems, and AI has enhanced the capabilities and reliability of these devices, encouraging their use in complex medical procedures. Expanding applications in diagnostics and preventive medicine are also driving market growth as healthcare providers seek early and accurate disease detection methods. Government initiatives and funding aimed at advancing nanotechnology, along with growing partnerships between research institutions and industry players, are further fueling innovation. Lastly, the increasing awareness of personalized medicine and the shift toward minimally invasive treatments are propelling the demand for nanorobots in healthcare, positioning the market for steady growth in the coming decade.

SCOPE OF STUDY:

The report analyzes the Nanorobots in Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Nanomanipulators, Bio-Nanorobotics, Magnetically Guided Nanorobots); Application (Targeted Drug Delivery Application, Medical Imaging Application, Surgical Application, Dental Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â